Previous studies have reported that abnormal expression of KGFR can be correlated with tumor progression, reduction of free survival and worse prognosis in different epithelial cancers, such as prostate, breast, gastric [38] and pancreatic [39] carcinomas. The gene discussed is FGFR2; the disease is neoplasm.